Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 3
1981 1
1982 2
1984 2
1985 1
1986 2
1987 6
1988 2
1989 1
1990 2
1991 2
1992 3
1993 3
1994 3
1995 4
1996 5
1997 2
1998 4
1999 5
2000 5
2001 5
2002 3
2003 7
2004 8
2005 12
2006 19
2007 25
2008 21
2009 27
2010 37
2011 55
2012 54
2013 69
2014 79
2015 115
2016 107
2017 127
2018 154
2019 169
2020 207
2021 233
2022 21
Text availability
Article attribute
Article type
Publication date

Search Results

1,422 results
Results by year
Filters applied: . Clear all
Page 1
Short- and potential long-term adverse health outcomes of COVID-19: a rapid review.
Leung TYM, Chan AYL, Chan EW, Chan VKY, Chui CSL, Cowling BJ, Gao L, Ge MQ, Hung IFN, Ip MSM, Ip P, Lau KK, Lau CS, Lau LKW, Leung WK, Li X, Luo H, Man KKC, Ng VWS, Siu CW, Wan EYF, Wing YK, Wong CSM, Wong KHT, Wong ICK. Leung TYM, et al. Among authors: ge mq. Emerg Microbes Infect. 2020 Dec;9(1):2190-2199. doi: 10.1080/22221751.2020.1825914. Emerg Microbes Infect. 2020. PMID: 32940572 Free PMC article.
Expert consensus workshop report: Guidelines for thermal ablation of thyroid tumors (2019 edition).
Xu D, Ge M, Yang A, Cheng R, Sun H, Wang H, Zhang J, Cheng Z, Wu Z, Wang Z, Zhai B, Che Y, Chen L, Chen L, Cheng W, Dong G, Duan P, Fan W, Fei J, Fu R, Gao M, Huang P, Jiang T, Kuang J, Li H, Li P, Li X, Li Z, Lu M, Luo Y, Qin H, Qin J, Tan Z, Tang L, Wang Z, Wang S, Wang X, Wu G, Xie X, Xu H, Yin D, Qiu X, Jichun Y, Yu J, Zhan W, Zhang F, Zhang J, Zheng R, Zheng X, Zheng Y, Zhu Y, Zou Y, Meng Z, Ye X, Li H, Li X, Lin Z, Wang L, Wang L, Yang C, Wang Y, Zhou L, Ou D, Wang J, Gao M, Xu H, Liang P, Teng G. Xu D, et al. Among authors: ge m. J Cancer Res Ther. 2020 Sep;16(5):960-966. doi: 10.4103/jcrt.JCRT_558_19. J Cancer Res Ther. 2020. PMID: 33004735 Free article. Review.
iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy.
Cichocki F, Bjordahl R, Gaidarova S, Mahmood S, Abujarour R, Wang H, Tuininga K, Felices M, Davis ZB, Bendzick L, Clarke R, Stokely L, Rogers P, Ge M, Robinson M, Rezner B, Robbins DL, Lee TT, Kaufman DS, Blazar BR, Valamehr B, Miller JS. Cichocki F, et al. Among authors: ge m. Sci Transl Med. 2020 Nov 4;12(568):eaaz5618. doi: 10.1126/scitranslmed.aaz5618. Sci Transl Med. 2020. PMID: 33148626
FBXO22 degrades nuclear PTEN to promote tumorigenesis.
Ge MK, Zhang N, Xia L, Zhang C, Dong SS, Li ZM, Ji Y, Zheng MH, Sun J, Chen GQ, Shen SM. Ge MK, et al. Nat Commun. 2020 Apr 6;11(1):1720. doi: 10.1038/s41467-020-15578-1. Nat Commun. 2020. PMID: 32249768 Free PMC article.
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy.
Woan KV, Kim H, Bjordahl R, Davis ZB, Gaidarova S, Goulding J, Hancock B, Mahmood S, Abujarour R, Wang H, Tuininga K, Zhang B, Wu CY, Kodal B, Khaw M, Bendzick L, Rogers P, Ge MQ, Bonello G, Meza M, Felices M, Huffman J, Dailey T, Lee TT, Walcheck B, Malmberg KJ, Blazar BR, Bryceson YT, Valamehr B, Miller JS, Cichocki F. Woan KV, et al. Among authors: ge mq. Cell Stem Cell. 2021 Dec 2;28(12):2062-2075.e5. doi: 10.1016/j.stem.2021.08.013. Epub 2021 Sep 14. Cell Stem Cell. 2021. PMID: 34525347
1,422 results